-+ 0.00%
-+ 0.00%
-+ 0.00%

Atara Biotherapeutics Reports Q2 2025 Net Income of $2.4M, EPS at $0.20; Revenue Boost from Tab-cel Transition to Pierre Fabre

Reuters·08/11/2025 20:01:59

Please log in to view news